MEDIJEL

This brand name is authorized in Cyprus, Hong Kong SAR China, Ireland, New Zealand, Singapore, UK.

Active ingredients

The drug MEDIJEL contains a combination of these active pharmaceutical ingredients (APIs):

1	Lidocaine UNII 98PI200987 - LIDOCAINE
	Lidocaine, like other local anaesthetics, causes a reversible blockade of impulse propagation along nerve fibres by preventing the inward movement of sodium ions through the nerve membrane. Local anaesthetics of the amide-type are thought to act within the sodium channels of the nerve membrane.
	Read more about Lidocaine
2	Aminoacridine UNII 78OY3Z0P7Z - AMINACRINE
	Read more about Aminoacridine

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
MEDIJEL Oral gel	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
A01AD11	Various	A Alimentary tract and metabolism → A01 Stomatological preparations → A01A Stomatological preparations → A01AD Other agents for local oral treatment
Discover more medicines within A01AD11

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
GB	Medicines & Healthcare Products Regulatory Agency	46135
HK	Department of Health Drug Office	07262
NZ	Medicines and Medical Devices Safety Authority	4455
SG	Health Sciences Authority	04748P